Raymond Brazenor Clayton - Publications

Affiliations: 
Biochemistry Stanford University, Palo Alto, CA 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1971 van Tamelen EE, Smaal JA, Clayton RB. Formation of A-B cis- and trans-19-norlanosterols by enzymic cyclization of 6'-norsqualene 2,3-oxide. Journal of the American Chemical Society. 93: 5279-81. PMID 5135874 DOI: 10.1021/ja00749a065  0.659
1970 van Tamelen EE, Hanzlik RP, Clayton RB, Burlingame AL. Minimal substrate structural requirements for lanosterol-squalene 2,3-oxide cyclase action. 10'-norsqualene 2,3-oxide. Journal of the American Chemical Society. 92: 2137-9. PMID 5435278 DOI: 10.1021/ja00710a060  0.707
1969 Crosby LO, Van Tamelen EE, Clayton RB. The role of substrate structure in the initiation of enzymic cyclization of squalene 2,3-oxide. Stereochemistry of homosterol formation from 1-methylsqualene 2,3-oxide Journal of the Chemical Society D: Chemical Communications. 532-533. DOI: 10.1039/C29690000532  0.735
1969 Stone KJ, Roeske WR, Clayton RB, Van Tamelen EE. Stereochemistry of sterol biosynthesis: Interrelationship of the terminal methyl groups in squalene, the C-1,1′ methyls in squalene 2,3-oxide, and the C-30,31 methyls in lanosterol Journal of the Chemical Society D: Chemical Communications. 530-532. DOI: 10.1039/C29690000530  0.507
1969 Anderson RJ, Hanzlik RP, Sharpless KB, Van Tamelen EE, Clayton RB. Enzymic transformation of an acyclic sesterterpene terminal epoxide into a lanosterol analogue Journal of the Chemical Society D: Chemical Communications. 53-54. DOI: 10.1039/C29690000053  0.599
1968 Godtfredsen WO, Lorck H, van Tamelen EE, Willett JD, Clayton RB. Biosynthesis of fusidic acid from squalene 2,3-oxide. Journal of the American Chemical Society. 90: 208-9. PMID 5688690 DOI: 10.1021/Ja01003A036  0.636
1968 Clayton RB, van Tamelen EE, Nadeau RG. The role of substrate structure in the initiation of enzymic cyclization of squalene 2,3-oxide. Studies with 2,3-cis-1'-norsqual ene 2,3-oxide and 2,3-trans-1'-norsqualene 2,3-oxide. Journal of the American Chemical Society. 90: 820-1. PMID 5638313 DOI: 10.1021/ja01005a065  0.74
1968 Van Tamelen EE, Hanzlik RP, Sharpless KB, Clayton RB, Richter WJ, Burlingame AL. Enzymic cyclization of 15-norsqualene 2,3-oxide Journal of the American Chemical Society. 90: 3284-3286. DOI: 10.1021/Ja01014A081  0.74
1967 van Tamelen EE, Sharpless KB, Hanzlik R, Clayton RB, Burlingame AL, Wszolek PC. Enzymic cyclization of trans,trans,trans-18,19-dihydrosqualene 2,3-oxide. Journal of the American Chemical Society. 89: 7150-1. PMID 6064361 DOI: 10.1021/Ja01002A077  0.723
1967 Willett JD, Sharpless KB, Lord KE, van Tamelen EE, Clayton RB. Squalene-2,3oxide, an intermediate in the enzymatic conversion of squalene to lanosterol and cholesterol. The Journal of Biological Chemistry. 242: 4182-91. PMID 6061706  0.669
1967 van Tamelen EE, Willett JD, Clayton RB. On the mechanism of lanosterol biosynthesis from squalene 2,3-oxide. Journal of the American Chemical Society. 89: 3371-3. PMID 6042776 DOI: 10.1021/Ja00989A063  0.68
1967 Van Tamelen EE, Sharpless KB, Willett JD, Clayton RB, Burlingame AL. Biological activities of some terminally modified squalene and squalene 2,3-oxide analogs Journal of the American Chemical Society. 89: 3920-3922. DOI: 10.1021/Ja00991A055  0.573
1966 Van Tamelen EE, Willett JD, Clayton RB, Lord KE. Enzymic conversion of squalene 2,3-oxide to lanosterol and cholesterol. Journal of the American Chemical Society. 88: 4752-4. PMID 5918048 DOI: 10.1021/Ja00972A058  0.704
Show low-probability matches.